For instance, EVs derived from human umbilical cord mesenchymal stem cells (Huc-MSCs) have been employed to treat liver fibrosis by reducing transforming growth factor-beta 1 (TGF-β1) expression and inhibiting liver EMT in vivo. The gene discussed is TGFB1; the disease is Hepatic fibrosis.